These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6729149)

  • 1. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
    Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G; Papp M; Scarpignato C
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
    de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
    Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin in the hormonal stimulation of amino acid uptake and pancreatic enzyme secretion.
    Konturek JW; Gabryelewicz A; Stoll R; Domschke W
    Ann N Y Acad Sci; 1994 Mar; 713():454-6. PubMed ID: 7514376
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A
    Regul Pept; 1990 Sep; 30(2):105-11. PubMed ID: 2274676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
    Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.
    Jansen JB; de Jong AJ; Singer MV; Niebel W; Rovati LC; Lamers CB
    Dig Dis Sci; 1990 Sep; 35(9):1073-7. PubMed ID: 2390922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
    Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
    Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
    Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
    Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.